We have further demonstrated that NDRG2 plays an important role in tumour cell glucose transport, during which NDRG2 promotes the degradation GLUT1 protein to suppress glucose uptake in breast cancer cells in vivo and in vitro. This evidence concerns the gene SLC2A1 and breast carcinoma.